Intravitreal bevacizumab (Avastin) for age-related macular degeneration: a critical analysis of literature
Author:
Publisher
Springer Science and Business Media LLC
Subject
Ophthalmology
Link
http://www.nature.com/articles/eye2009219.pdf
Reference75 articles.
1. Adamis AP, Shima DT . The role of vascular endothelial growth factor in ocular health and disease. Retina 2005; 25 (2): 111–118.
2. Ferrara N . Vascular endothelial growth factor: basic science and clinical progress. Endocr Rev 2004; 25 (4): 581–611.
3. Gragoudas ES, Adamis AP, Cunningham Jr ET, Feinsod M, Guyer DR . VEGF inhibition study in ocular neovascularization clinical trial group. Pegaptanib for neovascular age-related macular degeneration. N Engl J Med 2004; 351 (27): 2805–2816.
4. Brown DM, Michels M, Kaiser PK, Heier JS, Sy JP, Ianchulev T, ANCHOR Study Group. Ranibizumab versus verteporfin photodynamic therapy for neovascular age-related macular degeneration: Two-year results of the ANCHOR study. Ophthalmology 2009; 116 (1): 57–65.
5. Rosenfeld PJ, Brown DM, Heier JS, Boyer DS, Kaiser PK, Chung CY, MARINA Study Group. Ranibizumab for neovascular age-related macular degeneration. N Engl J Med 2006; 355 (14): 1419–1431.
Cited by 36 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Incidence of acute endophthalmitis after intravitreal bevacizumab injection in a tertiary hospital;Journal of Health Sciences and Medicine;2024-01-15
2. Controversies and Disparities in the Management of Age-Related Macular Degeneration;Seminars in Ophthalmology;2023-01-05
3. Posterior Segment Ophthalmic Drug Delivery: Role of Muco-Adhesion with a Special Focus on Chitosan;Pharmaceutics;2021-10-14
4. Ilimaquinone inhibits neovascular age-related macular degeneration through modulation of Wnt/β-catenin and p53 pathways;Pharmacological Research;2020-11
5. PET study of ocular and blood pharmacokinetics of intravitreal bevacizumab and aflibercept in rats;European Journal of Pharmaceutics and Biopharmaceutics;2020-09
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3